CUSIP 03969F109COMRCUSQ4 2025
50 filings · latest Jan 8, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Gilead Sciences, Inc. | 31.42M | $748.85M |
| 2 | Blackrock, Inc. | 15.00M | $357.40M |
| 3 | Vanguard Group Inc | 7.96M | $189.76M |
| 4 | Suvretta Capital Management, LLC | 5.19M | $123.65M |
| 5 | Wellington Management Group LLP | 5.18M | $123.55M |
| 6 | State Street Corp | 4.58M | $109.07M |
| 7 | Woodline Partners LP | 3.77M | $89.83M |
| 8 | Marshall Wace, LLP | 3.39M | $80.73M |
| 9 |
| 4 | Jul 15, 2025 | Gilead Sciences, Inc. | 13D/A | 29.7% | — | SEC |
| 5 | May 13, 2025 | Point72 Asset Management, L.P. | 13G | 5.5% | 5.83M | SEC |
| 6 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 9.4% | 9.98M | SEC |
| 7 | Mar 5, 2025 | Gilead Sciences, Inc. | 13D/A | 35.0% | — | SEC |
| 8 | Feb 20, 2025 | Gilead Sciences, Inc. | 13D/A | 35.0% | — | SEC |
| 9 | Dec 17, 2024 | Rosen Terry J | 13D/A | 4.1% | 3.79M | SEC |
| 10 | Nov 12, 2024 | Fmr LLC | 13G/A | 4.9% | — | SEC |
See the full Schedule 13D/13G history for Arcus Biosciences Inc.
Unlock full history| 3.28M |
| $78.16M |
| 10 | Siren, L.L.C. | 3.01M | $71.66M |